INNOVATE BIOPHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • October 29th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Innovate Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), confirms its agreement (this "Agreement") with H.C. Wainwright & Co., LLC ("HCW") and Ladenburg Thalmann & Co. Inc. ("Ladenburg", each of HCW and Ladenburg individually an "Agent" and collectively, the "Agents"), as follows:
